Genomic imprinting does not reduce the dosage of UBE3A in neurons

Abstract Background The ubiquitin protein E3A ligase gene (UBE3A) gene is imprinted with maternal-specific expression in neurons and biallelically expressed in all other cell types. Both loss-of-function and gain-of-function mutations affecting the dosage of UBE3A are associated with several neurode...

Full description

Bibliographic Details
Main Authors: Paul R. Hillman, Sarah G. B. Christian, Ryan Doan, Noah D. Cohen, Kranti Konganti, Kory Douglas, Xu Wang, Paul B. Samollow, Scott V. Dindot
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Epigenetics & Chromatin
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13072-017-0134-4
_version_ 1819060131054223360
author Paul R. Hillman
Sarah G. B. Christian
Ryan Doan
Noah D. Cohen
Kranti Konganti
Kory Douglas
Xu Wang
Paul B. Samollow
Scott V. Dindot
author_facet Paul R. Hillman
Sarah G. B. Christian
Ryan Doan
Noah D. Cohen
Kranti Konganti
Kory Douglas
Xu Wang
Paul B. Samollow
Scott V. Dindot
author_sort Paul R. Hillman
collection DOAJ
description Abstract Background The ubiquitin protein E3A ligase gene (UBE3A) gene is imprinted with maternal-specific expression in neurons and biallelically expressed in all other cell types. Both loss-of-function and gain-of-function mutations affecting the dosage of UBE3A are associated with several neurodevelopmental syndromes and psychological conditions, suggesting that UBE3A is dosage-sensitive in the brain. The observation that loss of imprinting increases the dosage of UBE3A in brain further suggests that inactivation of the paternal UBE3A allele evolved as a dosage-regulating mechanism. To test this hypothesis, we examined UBE3A transcript and protein levels among cells, tissues, and species with different imprinting states of UBE3A. Results Overall, we found no correlation between the imprinting status and dosage of UBE3A. Importantly, we found that maternal Ube3a protein levels increase in step with decreasing paternal Ube3a protein levels during neurogenesis in mouse, fully compensating for loss of expression of the paternal Ube3a allele in neurons. Conclusions Based on our findings, we propose that imprinting of UBE3A does not function to reduce the dosage of UBE3A in neurons but rather to regulate some other, as yet unknown, aspect of gene expression or protein function.
first_indexed 2024-12-21T14:22:06Z
format Article
id doaj.art-88bdb0bfe6834033969b214ce2186bc9
institution Directory Open Access Journal
issn 1756-8935
language English
last_indexed 2024-12-21T14:22:06Z
publishDate 2017-05-01
publisher BMC
record_format Article
series Epigenetics & Chromatin
spelling doaj.art-88bdb0bfe6834033969b214ce2186bc92022-12-21T19:00:45ZengBMCEpigenetics & Chromatin1756-89352017-05-0110111410.1186/s13072-017-0134-4Genomic imprinting does not reduce the dosage of UBE3A in neuronsPaul R. Hillman0Sarah G. B. Christian1Ryan Doan2Noah D. Cohen3Kranti Konganti4Kory Douglas5Xu Wang6Paul B. Samollow7Scott V. Dindot8Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityDepartment of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityDepartment of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityInstitute for Genome Science and Society, Texas A&M UniversityDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityDepartment of Molecular Biology and Genetics, Cornell UniversityDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityDepartment of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M UniversityAbstract Background The ubiquitin protein E3A ligase gene (UBE3A) gene is imprinted with maternal-specific expression in neurons and biallelically expressed in all other cell types. Both loss-of-function and gain-of-function mutations affecting the dosage of UBE3A are associated with several neurodevelopmental syndromes and psychological conditions, suggesting that UBE3A is dosage-sensitive in the brain. The observation that loss of imprinting increases the dosage of UBE3A in brain further suggests that inactivation of the paternal UBE3A allele evolved as a dosage-regulating mechanism. To test this hypothesis, we examined UBE3A transcript and protein levels among cells, tissues, and species with different imprinting states of UBE3A. Results Overall, we found no correlation between the imprinting status and dosage of UBE3A. Importantly, we found that maternal Ube3a protein levels increase in step with decreasing paternal Ube3a protein levels during neurogenesis in mouse, fully compensating for loss of expression of the paternal Ube3a allele in neurons. Conclusions Based on our findings, we propose that imprinting of UBE3A does not function to reduce the dosage of UBE3A in neurons but rather to regulate some other, as yet unknown, aspect of gene expression or protein function.http://link.springer.com/article/10.1186/s13072-017-0134-4Ube3aGenomic imprintingDosage compensationAngelman syndromeUbe3a antisenseEvolution
spellingShingle Paul R. Hillman
Sarah G. B. Christian
Ryan Doan
Noah D. Cohen
Kranti Konganti
Kory Douglas
Xu Wang
Paul B. Samollow
Scott V. Dindot
Genomic imprinting does not reduce the dosage of UBE3A in neurons
Epigenetics & Chromatin
Ube3a
Genomic imprinting
Dosage compensation
Angelman syndrome
Ube3a antisense
Evolution
title Genomic imprinting does not reduce the dosage of UBE3A in neurons
title_full Genomic imprinting does not reduce the dosage of UBE3A in neurons
title_fullStr Genomic imprinting does not reduce the dosage of UBE3A in neurons
title_full_unstemmed Genomic imprinting does not reduce the dosage of UBE3A in neurons
title_short Genomic imprinting does not reduce the dosage of UBE3A in neurons
title_sort genomic imprinting does not reduce the dosage of ube3a in neurons
topic Ube3a
Genomic imprinting
Dosage compensation
Angelman syndrome
Ube3a antisense
Evolution
url http://link.springer.com/article/10.1186/s13072-017-0134-4
work_keys_str_mv AT paulrhillman genomicimprintingdoesnotreducethedosageofube3ainneurons
AT sarahgbchristian genomicimprintingdoesnotreducethedosageofube3ainneurons
AT ryandoan genomicimprintingdoesnotreducethedosageofube3ainneurons
AT noahdcohen genomicimprintingdoesnotreducethedosageofube3ainneurons
AT krantikonganti genomicimprintingdoesnotreducethedosageofube3ainneurons
AT korydouglas genomicimprintingdoesnotreducethedosageofube3ainneurons
AT xuwang genomicimprintingdoesnotreducethedosageofube3ainneurons
AT paulbsamollow genomicimprintingdoesnotreducethedosageofube3ainneurons
AT scottvdindot genomicimprintingdoesnotreducethedosageofube3ainneurons